CNV screening in schizophrenia

WE ARE CURRENTLY RECRUITING FOR THIS STUDY.

Purpose: The purpose of this study is to assess clinical usefulness of copy number variant testing in individuals with schizophrenia, Copy number variants are rare genetic variants that can increase the risk for schizophrenia

Participants: Study participants are individuals who have a clinical diagnosis of schizophrenia or schizoaffective disorder.

Procedures (methods): We will test individuals with schizophrenia for copy number variants (CNV). After testing, positive results will be relayed to the clinician/treatment team to assess clinical value i.e. if this knowledge improves clinical care. Clinical value of CNV testing will be assessed by examining the diagnostic rates as well as the impact on treatment decisions including changes in medication management or other non-pharmacological treatment, referrals and follow-up care.